Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02321514 · ClinicalTrials.gov registry record · NA
Expanded Clinical Study of the Tendyne Mitral Valve System
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 191
- Enrollment target
NCT02321514 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 191 participants.
The verdict
NCT02321514, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 191 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and performance of the Tendyne Mitral Valve System in the treatment of severe mitral regurgitation in patents with functional disability greater than or equal to NYHA Class II, who are not suitable candidates for surgical replacement with otherwise available devices. Follow-up evaluations will be conducted through 5 years post implantation.
Interventions
- DEVICE Tendyne Mitral Valve System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2014-11 |
| Est. Completion | 2025-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02321514
The ClinicalTrials.gov registry entry for NCT02321514 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 191 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tendyne Mitral Valve System is the first listed.
NCT02321514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02321514 about?
NCT02321514 is a clinical study titled "Expanded Clinical Study of the Tendyne Mitral Valve System". The purpose of this study is to evaluate the safety and performance of the Tendyne Mitral Valve System in the treatment of severe mitral regurgitation in patents with functional disability greater than or equal to NYHA Class II, who are not suitable candidates for surgical replacement with otherwise...
What is the current status of trial NCT02321514?
This trial is currently completed. It is a NA study. The enrollment target is 191 participants. The study started on 2014-11. Estimated completion is 2025-04.
What interventions are being tested in trial NCT02321514?
The interventions under investigation include: Tendyne Mitral Valve System (DEVICE).
Who is sponsoring clinical trial NCT02321514?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.